Comparison of Tenofovir, Zidovudine, or Stavudine as Part of First-Line Antiretroviral Therapy in a Resource-Limited-Setting: A Cohort Study

BACKGROUND: Tenofovir (TDF) is part of the WHO recommended first-line antiretroviral therapy (ART); however, there are limited data comparing TDF to other nucleoside reverse transcriptase inhibitors in resource-limited-settings. Using a routine workplace and community-based ART cohort in South Afric...

Descripción completa

Detalles Bibliográficos
Autores principales: Velen, Kavindhran, Lewis, James J., Charalambous, Salome, Grant, Alison D., Churchyard, Gavin J., Hoffmann, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653880/
https://www.ncbi.nlm.nih.gov/pubmed/23691224
http://dx.doi.org/10.1371/journal.pone.0064459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653880/
https://www.ncbi.nlm.nih.gov/pubmed/23691224
http://dx.doi.org/10.1371/journal.pone.0064459

Ejemplares similares